TABLE 2.

Therapeutic targeting of FABP4 evaluated in different cancer types.

Methods	Cancer Type	Results	References
Inhibitor	Breast cancer	Inhibiting growth and metastasis	Uehara et al. (2014)
BMS309403
	Cholangiocarcinoma	Inhibiting metastasis	Yang et al. (2021)
	Colon cancer	Inhibiting metastasis	Tian et al. (2020)
	Hepatocellular carcinoma	Inhibiting growth and metastasis	Yan et al. (2018)
		Inhibiting growth and metastasis	Laouirem et al. (2019)
	Leukemia	Inhibiting growth	Yan et al. (2017)
	Liver cancer	Inhibiting growth and self-renewal	Wang et al. (2019)
	Ovarian cancer	Inhibiting growth and metastasis	Mukherjee et al. (2020)
		Increasing sensitivity to carboplatin
	Prostate cancer	Inhibiting metastasis	Nie et al. (2017)
Inhibitor BD62694	Ovarian cancer	Inhibiting recurrence	Tian et al. (2020)
siRNA	Hepatocellular carcinoma	Inhibiting growth and metastasis	Wang et al. (2019)
	Leukemia	Inhibiting growth	Yan et al. (2017)
	Ovarian cancer	Inhibiting metastasis	Gharpure et al. (2018)
shRNA	Triple-negative breast cancer	Inhibiting metastasis	Apaya et al. (2020)